Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

RGA entered the second half of 2026 with strong operating momentum: second-quarter adjusted operating income was $8.89 per diluted share and trailing-12-month adjusted operating ROE excluding notable items reached 18.4%, above the 13%-15% intermediate-term range. The company also returned $111 million to shareholders during the quarter and raised its quarterly dividend by 5.4%. These results support confidence in underwriting, investment execution, and capital management, but the latest quarter benefited from an unusually strong earnings level and reinsurance results remain exposed to biometric claims, investment-market, credit, and complex-transaction risks.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets9 analysts · as of 18 Aug 2026
Low · most bearish analyst$223.00
Mean target$266.89
High · most bullish analyst$302.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$223.0018%

Adverse mortality or morbidity experience, weaker investment results, credit deterioration, or execution challenges in complex in-force transactions drive adjusted operating ROE below the 13% lower bound of management's range. Reduced capital flexibility or weaker transaction returns would further impair the thesis.

Base CaseCentral scenario
$266.8958%
Matches the consensus mean

Earnings normalize from the exceptionally strong second quarter while adjusted operating ROE remains within or moderately above the 13%-15% intermediate-term range. New business, in-force transactions, and investment income support growth, offset by ordinary claims variability.

Bull CaseUpside scenario
$302.0024%

Sustained favorable claims experience, investment performance, and contributions from recently written and acquired business keep adjusted operating ROE above the 15% upper end of management's intermediate-term range. Disciplined transaction selection and shareholder distributions reinforce per-share value creation.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Trailing-12-month adjusted operating ROE excluding notable items was 18.4% at the second quarter of 2026, materially above the 13%-15% intermediate-term range.
  • Second-quarter adjusted operating income increased to $8.89 per diluted share from $4.72 a year earlier, while RGA returned $111 million to shareholders and increased its quarterly dividend to $0.98.
Sign in / Sign up to read more
Key Investment Risks
  • Life and health reinsurance earnings can vary materially with mortality, morbidity, policyholder behavior, and actuarial assumption experience.
  • A large, diversified investment portfolio and complex in-force transactions expose RGA to credit, market, liquidity, asset-liability, and transaction-execution risks.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.